NASDAQ · PRE
Healthcare · Medical - Diagnostics & Research
$16.19
Down-$0.15 (-0.93%)
Updated Nov 4, 2026, 10:33 PM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · PRE
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
PRE closed at $16.19 after 21 trading sessions, down 20.64% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $16.75 | $17.11 | $16.08 | $16.19 | 92.4K |
| Nov 2, 2026 | $18.10 | $18.275 | $15.755 | $16.47 | 266.27K |
| Oct 30, 2026 | $18.75 | $18.89 | $17.295 | $17.76 | 101.85K |
| Oct 29, 2026 | $18.38 | $19.28 | $18.3375 | $18.98 | 103.75K |
| Oct 28, 2026 | $18.49 | $18.87 | $18.19 | $18.52 | 118.1K |
| Oct 27, 2026 | $18.35 | $19.05 | $17.90 | $18.43 | 249.51K |
| Oct 26, 2026 | $17.84 | $18.72 | $17.84 | $18.37 | 115.79K |
| Oct 23, 2026 | $16.82 | $17.85 | $16.81 | $17.35 | 160.62K |
| Oct 22, 2026 | $16.78 | $17.557 | $16.03 | $16.57 | 290.32K |
| Oct 21, 2026 | $18.98 | $18.98 | $16.35 | $16.73 | 296.38K |
| Oct 20, 2026 | $19.04 | $19.88 | $18.55 | $18.63 | 92.9K |
| Oct 19, 2026 | $18.75 | $19.625 | $18.01 | $19.02 | 167.75K |
| Oct 16, 2026 | $20.11 | $20.38 | $18.05 | $18.52 | 334.71K |
| Oct 15, 2026 | $20.30 | $20.99 | $20.15 | $20.26 | 93.37K |
| Oct 14, 2026 | $21.30 | $21.64 | $20.40 | $20.60 | 154.66K |
| Oct 13, 2026 | $21.16 | $21.52 | $20.49 | $21.27 | 96.52K |
| Oct 12, 2026 | $21.10 | $21.66 | $20.705 | $21.16 | 143.48K |
| Oct 9, 2026 | $22.01 | $22.40 | $20.91 | $21.84 | 136K |
| Oct 8, 2026 | $22.24 | $23.15 | $21.51 | $22.00 | 509.71K |
| Oct 7, 2026 | $20.40 | $22.7999 | $20.35 | $22.47 | 283.4K |
| Oct 6, 2026 | $21.17 | $21.17 | $19.81 | $20.40 | 320.22K |
The latest Smart Investors Daily articles mentioning PRE.
Company
Market Activity
Research & News
PRE research
Company profile and research snapshot.
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 26, 2026 | Maxim Group | Buy | — |
| Oct 12, 2026 | Lucid Capital Markets | Buy | — |
| Sep 17, 2026 | Craig-Hallum | Buy | — |
| Aug 27, 2026 | B. Riley Securities | Buy | — |
| Jul 15, 2026 | Benchmark | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 26, 2026
Maxim Group analyst Thomas Forte initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy rating and announces Price Target of $41.
Yahoo · Oct 12, 2026
Photo: IM8 co-founder David Beckham; two-time NBA champion Chris Bosh; IM8 chief of staff and brand partnerships Samantha Kwok; and NBA executives (Credit: NBA) – IM8 will Host Fan Activation at an NBA House in the Region in 2027 – HONG KONG, Oct. 12, 2026 (GLOBE NEWSWIRE) -- The National Basketball Association (NBA) and IM8 (US) LLC, a premium health and longevity brand, today announced a multiyear collaboration that makes IM8 the Official Nutrition Partner of the NBA in Australia and eight mar
Benzinga · Oct 12, 2026
Lucid Capital Markets analyst Alex Nowark initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy rating and announces Price Target of $54.
Benzinga · Oct 7, 2026
– Reuters cites Dow Jones interview
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning PRE.
